Studies by Martignoni et al.30 and Martignoni et al.29 showed that following intravenous administration of rh-CRH, subjects with AD reached peak plasma cortisol levels faster than subjects without cognitive impairment, but the net cortisol elevation was similar in both groups. This evidence concerns the gene CRH and Alzheimer disease.